Kimberly Minarovich | Investor Relations, Argot Partners |
Nancy Lurker | President & Chief Executive Officer |
Scott Jones | Chief Commercial Officer |
Dana Flanders | Guggenheim |
Andrew D’Silva | B. Riley |
Edward Marks | H.C. Wainwright |
Good morning. My name is Sydney, and I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals Third Quarter 2019 Financial Results Conference Call. There will be a question-and-answer session to follow at the completion of the prepared remarks. Please be advised that this call is being recorded at the company's request.